0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2024 - FRS102_2024 500,000 500,000 xbrli:pure xbrli:shares iso4217:GBP 08250035 2024-01-01 2024-12-31 08250035 2024-12-31 08250035 2023-12-31 08250035 2023-01-01 2023-12-31 08250035 2023-12-31 08250035 2022-12-31 08250035 bus:RegisteredOffice 2024-01-01 2024-12-31 08250035 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 08250035 bus:Director1 2024-01-01 2024-12-31 08250035 bus:Director2 2024-01-01 2024-12-31 08250035 core:NetGoodwill 2024-12-31 08250035 core:WithinOneYear 2024-12-31 08250035 core:WithinOneYear 2023-12-31 08250035 core:ShareCapital 2024-12-31 08250035 core:ShareCapital 2023-12-31 08250035 core:RetainedEarningsAccumulatedLosses 2024-12-31 08250035 core:RetainedEarningsAccumulatedLosses 2023-12-31 08250035 bus:SmallEntities 2024-01-01 2024-12-31 08250035 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 08250035 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 08250035 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 08250035 bus:FullAccounts 2024-01-01 2024-12-31 08250035 core:NetGoodwill 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: 08250035
Dr Cliff Bucknall Medical Practice Limited
Unaudited Financial Statements
31 December 2024
Dr Cliff Bucknall Medical Practice Limited
Financial Statements
Year ended 31 December 2024
Contents
Page
Directors' report
1
Statement of financial position
2
Notes to the financial statements
3
The following pages do not form part of the financial statements
Chartered accountant's report to the board of directors on the preparation of the unaudited statutory financial statements
7
Dr Cliff Bucknall Medical Practice Limited
Directors' Report
Year ended 31 December 2024
The directors present their report and the unaudited financial statements of the company for the year ended 31 December 2024 .
Directors
The directors who served the company during the year were as follows:
Dr C Bucknall
Mrs C Bucknall
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 15 January 2025 and signed on behalf of the board by:
Dr C Bucknall
Director
Registered office:
York House
1 Seagrave Road
London
SW6 1RP
Dr Cliff Bucknall Medical Practice Limited
Statement of Financial Position
31 December 2024
2024
2023
Note
£
£
Creditors: amounts falling due within one year
6
24
24
----
----
Net current liabilities
24
24
----
----
Total assets less current liabilities
( 24)
( 24)
----
----
Net liabilities
( 24)
( 24)
----
----
Capital and reserves
Called up share capital
100
100
Profit and loss account
( 124)
( 124)
----
----
Shareholders deficit
( 24)
( 24)
----
----
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 15 January 2025 , and are signed on behalf of the board by:
Dr C Bucknall
Director
Company registration number: 08250035
Dr Cliff Bucknall Medical Practice Limited
Notes to the Financial Statements
Year ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is York House, 1 Seagrave Road, London, SW6 1RP.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Goodwill
-
Over five years
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
20% reducing balance
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
4. Intangible assets
Goodwill
£
Cost
At 1 January 2024 and 31 December 2024
500,000
---------
Amortisation
At 1 January 2024 and 31 December 2024
500,000
---------
Carrying amount
At 31 December 2024
–
---------
At 31 December 2023
–
---------
5. Tangible assets
Equipment
Total
£
£
Cost
At 1 January 2024 and 31 December 2024
9,568
9,568
-------
-------
Depreciation
At 1 January 2024 and 31 December 2024
9,568
9,568
-------
-------
Carrying amount
At 31 December 2024
–
–
-------
-------
At 31 December 2023
–
–
-------
-------
6. Creditors: amounts falling due within one year
2024
2023
£
£
Other creditors
24
24
----
----
7. Directors' advances, credits and guarantees
8. Related party transactions
The company was under the control of Dr Cliff Bucknall throughout the current and previous year. Dr Cliff Bucknall and Mrs Clare Bucknall are the shareholders of the company. No dividends were paid in the year or the previous year.
Dr Cliff Bucknall Medical Practice Limited
Management Information
Year ended 31 December 2024
The following pages do not form part of the financial statements.
Dr Cliff Bucknall Medical Practice Limited
Chartered Accountant's Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements of Dr Cliff Bucknall Medical Practice Limited
Year ended 31 December 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Dr Cliff Bucknall Medical Practice Limited for the year ended 31 December 2024, which comprise the statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/membership/regulations-standards-and-guidance. This report is made solely to the Board of Directors of Dr Cliff Bucknall Medical Practice Limited, as a body, in accordance with the terms of our engagement letter dated 7 April 2015. Our work has been undertaken solely to prepare for your approval the financial statements of Dr Cliff Bucknall Medical Practice Limited and state those matters that we have agreed to state to you, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF as detailed at www.icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Dr Cliff Bucknall Medical Practice Limited and its Board of Directors, as a body, for our work or for this report.
It is your duty to ensure that Dr Cliff Bucknall Medical Practice Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Dr Cliff Bucknall Medical Practice Limited. You consider that Dr Cliff Bucknall Medical Practice Limited is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the financial statements of Dr Cliff Bucknall Medical Practice Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
WYATTS Chartered accountants
York House 1 Seagrave Road London SW6 1RP
15 January 2025